GAIT DISTURBANCE and Celexa

PatientsVille

GAIT DISTURBANCE Symptoms and Causes

Multiple sclerosis (MS) is a nervous system disease that affects your brain and spinal cord. It damages the myelin sheath, the material that surrounds and protects your nerve cells. This damage slows down or blocks messages between your brain and your body, leading to the symptoms of MS. They can include

Visual disturbances
Muscle weakness
Trouble with coordination and balance
Sensations such as numbness, prickling, or "pins and needles"
Thinking and memory problems

No one knows what causes MS. It may be an autoimmune disease, which happens when your immune system attacks healthy cells in your body by mistake. Multiple sclerosis affects women more than men. It often begins between the ages of 20 and 40. Usually, the disease is mild, but some people lose the ability to write, speak, or walk.

There is no single test for MS. Doctors use a medical history, physical exam, neurological exam, MRI, and other tests to diagnose it. There is no cure for MS, but medicines may slow it down and help control symptoms. Physical and occupational therapy may also help.

NIH: National Institute of Neurological Disorders and Stroke

Check out the latest treatments for GAIT DISTURBANCE

➢ GAIT DISTURBANCE treatment research studies

➢ Celexa clinical trials, surveys and public health registries

Find Drug Side Effect reports

Celexa Side Effects

Dizziness (136)

Nausea (135)

Anxiety (127)

Suicidal Ideation (124)

Depression (123)

Headache (120)

Completed Suicide (120)

Pain (111)

Insomnia (109)

Feeling Abnormal (102)

Vomiting (101)

Diarrhoea (99)

Fall (96)

Fatigue (91)

Loss Of Consciousness (89)

Tremor (89)

Dyspnoea (85)

Agitation (78)

Confusional State (76)

Aggression (69)

Asthenia (38)

Convulsion (34)

Suicide Attempt (33)

Condition Aggravated (32)

Abnormal Behaviour (32)

Weight Increased (31)

Somnolence (30)

Anger (30)

Pulmonary Embolism (28)

Malaise (28)

Chest Pain (28)

Crying (27)

Irritability (27)

Abdominal Pain Upper (25)

Abdominal Pain (25)

Constipation (25)

Overdose (25)

Serotonin Syndrome (25)

Paraesthesia (25)

Syncope (24)

Amnesia (24)

Hyperhidrosis (24)

Intentional Self-injury (22)

Hypertension (21)

Arthralgia (21)

Injury (20)

Palpitations (20)

Heart Rate Increased (20)

Blood Pressure Increased (20)

Rash (19)

➢ More

Common Meds

Abilify (10132)

Adderall (1304)

Amlodipine (6664)

Amoxicillin (4387)

Benadryl (1568)

Celebrex (12876 )

Celexa (1342)

Cialis (2975)

Cipro (8580)

Citalopram (7792)

Crestor (18839)

Cymbalta (14373)

Doxycycline (1757)

Effexor (7289)

Flexeril (435)

Flomax (2177)

Fluoxetine (4261)

Gabapentin (4593)

Hydrocodone (2469)

Ibuprofen (8222)

Lantus (10968)

Lexapro (3499)

Lipitor (17769)

Lisinopril (8919)

Lyrica (27148)

Medrol (650)

Mirena (41254)

Mobic (957)

Morphine (5356)

Naproxen (538)

Neurontin (6501)

Oxycodone (4438)

Pradaxa (13372)

Prednisone (5926)

Prilosec (2631)

Prozac (1954)

Seroquel (27216)

Simvastatin (8348)

Synthroid (4452)

Tamiflu (5585)

Topamax (3748)

Tramadol (5054)

Trazodone (1458)

Viagra (5394)

Vicodin (1153)

Wellbutrin (6324)

Xanax (2847)

Zocor (5718)

Zoloft(6792)

Zyrtec(1669)

Recent Reviews

Can ratio-citalopram be taken long term with Lectopam 6 mg?

Celexa triggered my tourettes syndrome. Three weeks after starting this med, I started having motor and vocal tics. Do not advise anyone to take this drug. It sucks.

I need to find out if Celexa is available in Ecuador as I will be living there for several months. Thanks.

I Took celexa for about 7 years im a 28 year old male. A couple months after getting off of the drug I have been twitching all over my body. Feet, legs,thighs,arms,stomach,hands,face,everywhere. I also have this feeling of a lump stuck in my throat.

It probably didn't trigger your TS. It was probably just supressing symptoms to a point where they were un noticable. Celexa is something they use to help alleviate the symptoms. so when you came off of it, they came back. They could have developed w

Tremendous fear of falling when attempting to walk in wide open spaces. For some reason, I just freeze up and cannot move due to an enormous fear of falling. Please let me know if there's a way to correct this condition. I am an 8 year stroke surv

I have been taking Atenolol for the past five years and still experience side effects such as unsteady gait,cold hands and feet, occasional chest pain, dizziness, and headaches. I work as a PCAon the

49 yo woman, regular medication Promethazine 50mg nocte for allergies. Commenced Mobic 15 mg 2/7 ago. Currently expereincing severe headaches, tiredness, blurred vision and sleep disturbance - eg vivid dreaming/ hallucinations. Are these k

After using Apidra for two months, I am experiencing the following symptoms- anxiety, shakiness, rash over body, digestive tract disturbance and fainting spells. I am discontinuing my use of Apidra due to these side effects and will return to Humalog

Been taking this for a while now, suffering from Sleep Disturbance, Weakness when lifting things, Sexual problems and joint pain in the Knee's, Hips and Ankles. I played Footbal with my son the other day but had to stop because of the pain in my knee

Continually having dizzy spells and to the point of blacking out and unbalanced in gait. Dosage 4 mg nocte

Hi Michele. I take Lamictal and it can cause sleep disturbance initially, but generally settles down. What worked for me was to start in very small doses, wait til the sleeping settled, then slowly up the dose, making sure to let the sleeping settle

I became a cardiac cripple on bicor...started with all the side effects of sleep disturbance and nausea and extreme tiredness but the really scary things were the increase in irregular heart beats, could not walk up even a small incline without being

I have been on this drug for two coming three weeks, so far I have suffered terrible sickness and diahorrea, pain on the left side of my head, disturbance in my vision and nose bleeds. I am getting some night terrors-disturbing dreams that would exp

Ihave osteo., and am waiting for total knee replacement..i can colerate endone but onlt take half a tablet at a time 2 in24 hours. side effects muddle brain can barely function yet have to take some pain relief as my gait is affecting those

Im on champix 8 days now and five minutes after i took the blue pill (1mg) bang side effects: cramps, tiredness,lower back pains, pins and needles in feet, sleep disturbance so on so forth. None of these affected me on the white pill (0.5mg

GAIT DISTURBANCE Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.

Rank

Status

Study

Recruiting

EScitalopram PIndolol ONset of Action

Condition:	Unipolar Depression
Interventions:	Drug: escitalopram, pindolol; Drug: escitalopram
Outcome Measures:	MADRS score change between baseline and 2 weeks of treatment; Response/remission (MADRS) at 6 weeks; Adverse events; Correlation of drug level of pindolol and/or escitalopram and clinical outcome (primary outcome) between treatment groups

Recruiting

Lexapro®'s Efficacy After Dose Escalation in Remission Study

Condition:	Major Depressive Disorder
Intervention:	Drug: escitalopram
Outcome Measures:	Montgomery-Åsberg Depression Rating Scale (MADRS); Hamilton Depression Rating Scale-17 items (HAM-D); Hamilton Anxiety Rating Scale (HAM-A); Clinical Global Impression-severity (CGI-S); Clinical Global Impression-Improvement (CGI-I); Beck's Depression Inventory(BDI); WHO Quality Of Life scale Abbreviated Version(WHOQOL-BREF); Clinically Useful Depression Outcome Scale (CUDOS); Short From-36 Health survey (SF-36 Health survey)

Unknown ^†

Circadian Effects of Escitalopram

Condition:	Depression
Intervention:	Drug: placebo/escitalopram
Outcome Measures:	Resetting effect of Escitalopram on the circadian pacemaker; Correlation between improvement in depression with Escitalopram and the degree of realignment between the timing of sleep and the timing of the biological clock.

Recruiting

Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial

Conditions:	Major Depressive Disorder; Major Depressive Disorder, Recurrent, Unspecified; Major Depressive Disorder, Single Episode, Unspecified
Interventions:	Drug: Escitalopram oxalate; Device: transcranial direct current stimulation
Outcome Measures:	Change in Hamilton Rating Scale for Depression, 17 items (HAMD17); Change in Montgomery-Asberg Depression Rating Scale (MADRS); Change in Beck Depression Inventory (BDI); Hamilton Rating Scale for Depression, 17 items (HAMD17)

Recruiting

Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder

Conditions:	Irritable Bowel Syndrome; Panic Disorder
Intervention:	Drug: Escitalopram
Outcome Measures:	Gastrointestinal Symptom Rating Scale (GSRS).; State Trait Anxiety Inventory (STAI).

Unknown ^†

Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain

Conditions:	Low Back Pain; Depression
Interventions:	Drug: Escitalopram; Drug: Placebo
Outcome Measures:	In comparison to placebo-treated patients, patients with treated with Cipralex report a significant reduction in depressive symptoms (>= 50% HAMD score) after 4 weeks of treatment.; In comparison to placebo, subjects treated with Cipralex report a significant reduction in pain intensity (>= 50% reduction of pain questionnaire score or VAS) after 12 weeks of treatment.; In comparison with placebo, subjects treated with Cipralex report a significant improvement in physical and everyday functioning after 12 weeks of treatment.; Personality traits do not have a significant influence on outcome regarding depressive traits, pain intensity and functioning.; Personality disorders are significantly influencing worse outcome regarding depressive traits, pain intensity and functioning.

Recruiting

DECIFER: DEpression and Citalopram In First Episode Recovery

Conditions:	Schizophrenia; Schizophreniform Disorder
Interventions:	Drug: Citalopram; Behavioral: Psychoeducation; Behavioral: Cognitive Behavioral Therapy (CBT); Radiation: Functional Magnetic Resonance Imaging (fMRI); Drug: Placebo
Outcome Measures:	Calgary Depression Scale for Schizophrenia (CDSS); Scale for the Assessment of Negative Symptoms (SANS); Brief Psychiatric Rating Scale (BPRS); InterSePT Scale for Suicidal Thinking (ISST); Heinrich Quality of Life Scale (QOL)

Not yet recruiting

Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)

Condition:	Major Depressive Disorder (MDD)
Interventions:	Drug: Agomelatine; Drug: Escitalopram
Outcome Measures:	Change from baseline in markers of sympathetic nervous system activity.; Change from baseline in the magnitude of morning surge in blood pressure.; To determine the association between sympathetic nervous system activity and left ventricular hypertrophy.; Change from baseline in insulin resistance.; Change from baseline on markers of cardiac risk.

Unknown ^†

Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7)

Condition:	Major Depression
Interventions:	Drug: escitalopram; Drug: nortriptyline
Outcome Measures:	Hamilton depression rating scale; Drop out due to side-effects of drugs

Recruiting

Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics

Condition:	Alcohol Dependence
Intervention:	Drug: citalopram
Outcome Measures:	Craving for alcohol in type B alcohol dependence with citalopram compared to placebo; Striatal dopamine receptor availability in type B alcohol dependence with citalopram, compared to placebo

Unknown ^†

The Effects of Escitalopram on Cytokines

Condition:	Depression
Intervention:	Drug: Escitalopram
Outcome Measures:	The changes in cytokines; The changes in Hamilton Depression Rating Scale

Recruiting

Brain Aging and Treatment Response in Geriatric Depression

Conditions:	Mild Neurocognitive Disorder; MCI; Depression
Interventions:	Drug: Escitalopram; Drug: Memantine; Drug: Placebo
Outcome Measures:	Change in Hamilton Depression Rating Scale (HDRS) scores; Change in cognitive domain scores

Unknown ^†

Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning

Conditions:	Depression; Continuous Antidepressant Abuse; Adverse Reaction to Drug
Intervention:	Drug: Escitalopram
Outcome Measures:	antidepressant response at 2,4,6,8 weeks A/E monitoring at 1,2,4,6,8 weeks; biological value at 0 week and 8 weeks

Not yet recruiting

The ISLAND Study: InSuLa Assessed Needs for Depression

Condition:	Depression
Interventions:	Drug: Escitalopram; Behavioral: Cognitive Behavioral Therapy; Other: Combination treatment (Escitalopram + CBT)
Outcome Measures:	Remission from major depressive episode; Response to treatment

Unknown ^†

Citalopram for Cocaine Dependence

Condition:	Cocaine Dependence
Interventions:	Drug: Citalopram; Drug: Placebo
Outcome Measures:	Abstinence; Cocaine Use Days; Cocaine-negative Urines; Retention in Treatment

Recruiting

A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom

Condition:	Depressive Disorder, Major
Intervention:	Drug: Escitalopram
Outcome Measures:	Change From Baseline in Quality of Life Enjoyment and Satisfaction Questionnaire, Short Form (Q-LES-Q-SF); Change From Baseline in Sheehan Disability Scale (SDS); Remission Rate at Week 8; Onset of Effect Rate at Week 1; Onset of Effect Rate at Week 2; Change From Baseline to Week 8 in Montgomery-Asberg Depression Rating Scale (MADRS) Scores; Change From Baseline to Week 8 in Hamilton Anxiety Scale (HAMA) Scores; Change From Baseline to Week 8 in Inventory of Depressive Symptomatology, Self-Report (QIDS-SR) Scores

Unknown ^†

Cipralex® for Anxiety Disorders in Adolescents

Condition:	Anxiety Disorder
Intervention:	Drug: Cipralex®
Outcome Measures:	Treatment Efficacy; Physiological response to stress; Suicide risk

Recruiting

Effects of Intravenous (IV) Citalopram on Emotional Brain Activity in Healthy Young and Elderly Adults

Condition:	Healthy Young and Elderly Volunteers
Interventions:	Drug: Intravenous Citalopram; Drug: Normal Saline
Outcome Measures:	BOLD fMRI Response; Genetics and Cognitive/Emotional Change

Unknown ^†

Cognitive Behavioural Analysis System of Psychotherapy (CBASp) Versus Escitalopram in Chronic Depression

Condition:	Chronic Depression
Interventions:	Other: CBASP psychotherapy; Drug: Escitalopram
Outcome Measures:	Depressive symptomatology after 8 weeks after randomization as measured by the MADRS; Depressive symptoms and remission 28 weeks after randomization; social, interpersonal and work function 28 weeks after randomization

Unknown ^†

Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy

Condition:	Marijuana Dependence
Intervention:	Drug: Escitalopram
Outcome Measures:	Clean urine THC samples; Questionnaire ratings of anxiety and depression and withdrawal symptoms